pending 2023 WO2025137323A1
Treatment of CPN1 Related Diseases and Disorders
Inventors: Gregory McInnes
Plain Language Summary
Compositions comprising oligonucleotides (siRNA or ASO) that target CPN1 for treating conditions associated with CPN1 gene mutations.
RNA Therapeutics